About Michael Mendelsohn
Michael Mendelsohn is a director at Foghorn Therapeutics.
Form D filings name Michael Mendelsohn as an executive officer and director at Cardurion Pharmaceuticals.
Michael Mendelsohn reports to the SEC as a director of 3 public companies, including Korsana Biosciences (KRSA) and Tobira Therapeutics (TBRA).
Michael Mendelsohn first appears on SEC filings in 2013.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Mendelsohn in the role, so the role may have started earlier or lasted longer.
FI
Foghorn Therapeutics Inc.
Director
2020 – 2026 · Public company (FHTX)
KI
Korsana Biosciences, Inc.
Director
2019 – 2022 · Public company (KRSA)
TI
Tobira Therapeutics, Inc.
Director
2013 – 2015 · Public company (TBRA)
Key Colleagues at Startups
The people Michael Mendelsohn works with at each company, as listed on that company's latest Form D.
Cardurion Pharmaceuticals, Inc. · Form D, Jul 24, 2024
ER
Evan Rachlin
Director
Jeb Keiper
Director
DL
Daniel Lynch
Director
ER
Emma Reeve
Director
PL
Peter Lawrence
President and Chief Executive Officer, director
EM
Edward Mathers
Director
AK
Adam Koppel
Director
ND
Nicholas Downing
Director